AngioSoma and its Subsidiary SomaCeuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
11. Februar 2021 10:42 ET
|
AngioSoma, Inc.
Houston, TX, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”), through its wholly-owned subsidiary, SomaCeuticals, Inc., is pleased to...
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
08. Dezember 2020 09:30 ET
|
AngioSoma, Inc.
Houston, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company’s subsidiary, SomaCeuticals, Inc.,...
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis
24. August 2020 12:10 ET
|
AngioSoma, Inc.
Houston, TX, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the company’s subsidiary, SomaCeuticals,...
SomaCeuticals Elects New President
17. August 2020 10:45 ET
|
AngioSoma, Inc.
Houston, TX, Aug. 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the company’s subsidiary, SomaCeuticals,...
AngioSoma Focusing on Development of Coating for Metal Stents
27. Mai 2020 10:42 ET
|
AngioSoma, Inc.
Houston, TX, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company is focusing on development and...
AngioSoma's Development of Atherectomy Catheter
20. Mai 2020 09:54 ET
|
AngioSoma, Inc.
Houston, TX, May 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that the Company’s peripheral arterial disease...
AngioSoma Continues to Liquidate Debt
21. April 2020 09:53 ET
|
AngioSoma, Inc.
Houston, TX, April 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced that holders of the Company's 12% unsecured convertible...
AngioSoma Moving Forward With Exciting New Products
09. März 2020 11:10 ET
|
AngioSoma, Inc.
Houston, TX, March 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced creating an innovative marketing strategy for its 15...
AngioSoma Announces Trademark Allowed for Muscles4U
22. Januar 2020 09:30 ET
|
AngioSoma, Inc.
Houston, TX, Jan. 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that we have received official notice of allowance...
AngioSoma Acquires Technology Related to 15 Patents
15. Januar 2020 09:30 ET
|
AngioSoma, Inc.
Houston, Jan. 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) is pleased to announce that we have acquired the unconditional ownership of...